Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Solventum Corporation
Solventum sells medical supplies and healthcare software—wound dressings, dental products, and health information systems—to hospitals, clinics, and dental professionals.
Solventum makes the unglamorous stuff that hospitals and clinics run on every day. It sells wound-care dressings and skin products, dental supplies and orthodontic materials, and software that hospitals use to keep track of patient records and get paid by insurers. The company was spun off from 3M in April 2024, so it is young as a standalone business even though many of its products have been sold for decades.
The business splits into three broad pieces. The medical-surgical side makes wound dressings, surgical supplies, and devices for keeping patients safe from infection. The dental side sells brackets, adhesives, and other gear that orthodontists and dentists use. The health information systems unit sells software that helps hospitals document care and manage billing—a business that generated steady revenue but faced tough competition and slower growth, which is why Solventum agreed in 2025 to sell that unit to Thermo Fisher Scientific for about $4.1 billion. Hospitals and dental offices pay for these products because switching suppliers is a hassle and the clinical stakes are high—a nurse does not want to gamble on a cheap wound dressing. That brand trust and deep hospital relationships are the company's real moat. But the spin-off came with heavy debt, and the company has been working to pay it down, partly with the proceeds from the software-unit sale.
The honest picture: Solventum is a collection of solid, cash-generating healthcare franchises that were buried inside a conglomerate for years. Management's job now is to slim down, fix underperforming pieces, and prove the parts are worth more on their own than they were inside 3M.
Saved answer · last researched 12 Nov 2026